
Olga V. Tcherkasskaya
Examiner (ID: 5403, Phone: (571)270-3672 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 928 |
| Issued Applications | 461 |
| Pending Applications | 124 |
| Abandoned Applications | 380 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13686323
[patent_doc_number] => 20170354116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHOD FOR REDUCING INCIDENCE OF MASTITIS IN DAIRY ANIMALS USING AMINE OXIDE ANTISEPTIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/617986
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617986
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/617986 | METHOD FOR REDUCING INCIDENCE OF MASTITIS IN DAIRY ANIMALS USING AMINE OXIDE ANTISEPTIC COMPOSITIONS | Jun 7, 2017 | Abandoned |
Array
(
[id] => 14435271
[patent_doc_number] => 20190175507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/306220
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306220
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306220 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Jun 1, 2017 | Abandoned |
Array
(
[id] => 16939820
[patent_doc_number] => 11052034
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => Cosmetic for correcting bumps and dips
[patent_app_type] => utility
[patent_app_number] => 16/304318
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5390
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304318 | Cosmetic for correcting bumps and dips | May 24, 2017 | Issued |
Array
(
[id] => 11948329
[patent_doc_number] => 20170252481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'THERMOFORMED POLY-4-HYDROXYBUTYRATE MEDICAL IMPLANTS'
[patent_app_type] => utility
[patent_app_number] => 15/599975
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7782
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599975 | Thermoformed poly-4-hydroxybutyrate medical implants | May 18, 2017 | Issued |
Array
(
[id] => 15975473
[patent_doc_number] => 10668037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Treatment for chronic kidney disease
[patent_app_type] => utility
[patent_app_number] => 15/599345
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5525
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599345
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599345 | Treatment for chronic kidney disease | May 17, 2017 | Issued |
Array
(
[id] => 11945257
[patent_doc_number] => 20170249408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/597391
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34267
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597391
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597391 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | May 16, 2017 | Abandoned |
Array
(
[id] => 11945256
[patent_doc_number] => 20170249407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions'
[patent_app_type] => utility
[patent_app_number] => 15/597376
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34305
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597376 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | May 16, 2017 | Abandoned |
Array
(
[id] => 17936970
[patent_doc_number] => 11471402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Hydrogel-based biological delivery vehicle
[patent_app_type] => utility
[patent_app_number] => 16/300660
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 17236
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300660 | Hydrogel-based biological delivery vehicle | May 11, 2017 | Issued |
Array
(
[id] => 14273549
[patent_doc_number] => 20190134059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/099265
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099265 | FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE | May 4, 2017 | Abandoned |
Array
(
[id] => 14611755
[patent_doc_number] => 10358563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Core-shell metal nanoparticle composite
[patent_app_type] => utility
[patent_app_number] => 15/586643
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5988
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586643 | Core-shell metal nanoparticle composite | May 3, 2017 | Issued |
Array
(
[id] => 13165489
[patent_doc_number] => 10098835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Process for making controlled release medical implant and non-implant products
[patent_app_type] => utility
[patent_app_number] => 15/583579
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 6399
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583579 | Process for making controlled release medical implant and non-implant products | Apr 30, 2017 | Issued |
Array
(
[id] => 12022270
[patent_doc_number] => 20170312369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'LIQUID PENTABLOCK CO-POLYMER FORMULATIONS FOR SUSTAINED DELIVERY OF THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 15/582685
[patent_app_country] => US
[patent_app_date] => 2017-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11930
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15582685
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/582685 | Liquid pentablock co-polymer formulations for sustained delivery of therapeutics | Apr 28, 2017 | Issued |
Array
(
[id] => 11834442
[patent_doc_number] => 20170216161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'HIGH STRENGTH MICROCAPSULES'
[patent_app_type] => utility
[patent_app_number] => 15/487491
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 50098
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487491
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487491 | HIGH STRENGTH MICROCAPSULES | Apr 13, 2017 | Abandoned |
Array
(
[id] => 16604666
[patent_doc_number] => 10905649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Injectable composition for delivery of a biologically active agent
[patent_app_type] => utility
[patent_app_number] => 16/092636
[patent_app_country] => US
[patent_app_date] => 2017-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 24877
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092636 | Injectable composition for delivery of a biologically active agent | Apr 10, 2017 | Issued |
Array
(
[id] => 12126183
[patent_doc_number] => 20180009769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'Novel formulation of metaxalone'
[patent_app_type] => utility
[patent_app_number] => 15/482598
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 38636
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15482598
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/482598 | Novel formulation of metaxalone | Apr 6, 2017 | Abandoned |
Array
(
[id] => 15738257
[patent_doc_number] => 20200108016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
[patent_app_type] => utility
[patent_app_number] => 16/500944
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36660
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500944 | SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE | Apr 5, 2017 | Abandoned |
Array
(
[id] => 16891943
[patent_doc_number] => 11033468
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Liquid dispersion and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/097785
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8673
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097785
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/097785 | Liquid dispersion and uses thereof | Apr 4, 2017 | Issued |
Array
(
[id] => 16428025
[patent_doc_number] => 10828083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Lactoferrin-conjugated nanoparticle complex and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/471905
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 41
[patent_no_of_words] => 10420
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471905 | Lactoferrin-conjugated nanoparticle complex and use thereof | Mar 27, 2017 | Issued |
Array
(
[id] => 13049311
[patent_doc_number] => 10046032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Use of insulin for promoting gastric emptying
[patent_app_type] => utility
[patent_app_number] => 15/468965
[patent_app_country] => US
[patent_app_date] => 2017-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9999
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15468965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/468965 | Use of insulin for promoting gastric emptying | Mar 23, 2017 | Issued |
Array
(
[id] => 15419743
[patent_doc_number] => 10542770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Cannabinoid emulsion product and process for making the same
[patent_app_type] => utility
[patent_app_number] => 15/462495
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9112
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462495 | Cannabinoid emulsion product and process for making the same | Mar 16, 2017 | Issued |